CA27469/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	1
1997	1
2000	5
2002	5
2003	8
2004	5
2005	3
2006	1
2007	8
2008	10
2009	4
2010	3
2011	9
2012	9
2013	3
2014	4
2015	4
2016	4
2024	0

1

Inherited Mutations in Women With Ovarian Carcinoma.

Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, Bernards SS, Casadei S, Yi Q, Burger RA, Chan JK, Davidson SA, Mannel RS, DiSilvestro PA, Lankes HA, Ramirez NC, King MC, Swisher EM, Birrer MJ. Norquist BM, et al. JAMA Oncol. 2016 Apr;2(4):482-90. doi: 10.1001/jamaoncol.2015.5495. JAMA Oncol. 2016. PMID: 26720728 Free PMC article.

2

Progesterone: the ultimate endometrial tumor suppressor.

Yang S, Thiel KW, Leslie KK. Yang S, et al. Trends Endocrinol Metab. 2011 Apr;22(4):145-52. doi: 10.1016/j.tem.2011.01.005. Epub 2011 Feb 25. Trends Endocrinol Metab. 2011. PMID: 21353793 Free PMC article. Review.

3

Endometrial cancer.

Leslie KK, Thiel KW, Goodheart MJ, De Geest K, Jia Y, Yang S. Leslie KK, et al. Obstet Gynecol Clin North Am. 2012 Jun;39(2):255-68. doi: 10.1016/j.ogc.2012.04.001. Obstet Gynecol Clin North Am. 2012. PMID: 22640714 Free PMC article.

4

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.

Reyes HD, Thiel KW, Carlson MJ, Meng X, Yang S, Stephan JM, Leslie KK. Reyes HD, et al. Mol Diagn Ther. 2014 Apr;18(2):137-51. doi: 10.1007/s40291-013-0070-3. Mol Diagn Ther. 2014. PMID: 24403167 Free PMC article. Review.

5

Endometrial cancer: reviving progesterone therapy in the molecular age.

Yang S, Thiel KW, De Geest K, Leslie KK. Yang S, et al. Discov Med. 2011 Sep;12(64):205-12. Discov Med. 2011. PMID: 21955848 Free article. Review.

6

Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer.

Carlson MJ, Thiel KW, Yang S, Leslie KK. Carlson MJ, et al. Discov Med. 2012 Sep;14(76):215-22. Discov Med. 2012. PMID: 23021376 Free PMC article. Review.

7

Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy.

Robinson AA, Watson WJ, Leslie KK. Robinson AA, et al. Lancet Oncol. 2007 Aug;8(8):738-43. doi: 10.1016/S1470-2045(07)70242-5. Lancet Oncol. 2007. PMID: 17679084 Review.

8

Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.

Wagner LI, Wenzel L, Shaw E, Cella D. Wagner LI, et al. J Clin Oncol. 2007 Nov 10;25(32):5058-62. doi: 10.1200/JCO.2007.11.7275. J Clin Oncol. 2007. PMID: 17991921 Review.

9

A role for Ubc9 in tumorigenesis.

Mo YY, Yu Y, Theodosiou E, Ee PL, Beck WT. Mo YY, et al. Oncogene. 2005 Apr 14;24(16):2677-83. doi: 10.1038/sj.onc.1208210. Oncogene. 2005. PMID: 15735760

10

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC; Gynecologic Oncology Group. Chan JK, et al. Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390. Cancer. 2008. PMID: 18348296 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year